Search Results
Clinical Data with PARP Inhibitors in Ovarian Cancer
PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023
Ongoing Clinical Trials with PARP Inhibitors in Ovarian Cancer
Expert report on survival data from pivotal trials with PARP inhibitors for BRCA-mut. Ovarian Cancer
Differences Among PARP Inhibitors in Ovarian Cancer
Navigating Rapid Change in Ovarian Cancer: PARP Inhibitors in Clinical Pathways
New Clinical Data Highlight Effect of PARP Inhibitors on Ovarian Cancer Treatment
The promising potential of PARP inhibitors in ovarian cancer
Dr. McCann on Combination Trials With PARP Inhibitors in Ovarian Cancer
Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel Approaches
Expert Perspectives: The Clinical Potential of PARP Inhibitors in Ovarian Cancer
The Therapeutic Potential of Novel PARP Inhibitors in the Clinic for Epithelial Ovarian Cancer